Knobbe News

Knobbe Martens partner Ben Shiroma shared reflections on his path to becoming an IP litigation partner at the firm and his approach to long-term career growth in Am Law’s “How...

IRVINE, Calif., August 27, 2026 – Knobbe Martens is proud to share that five of the firm’s partners were named in the 2026 edition of Benchmark Litigation’s “40 & Under”...

Knobbe Martens partner Jarom Kesler discussed how U.S. Patent and Trademark Office (USPTO) patent examiner statistics can inform patent prosecution strategy in a recent Managing Intellectual Property article. The article...

On September 1, 2026, medical device company DermaSensor Inc. announced four new industry partnerships. DermaSensor is focused on early detection of skin cancer. DermaSensor’s website states: “The DermaSensor device is the...

Key Takeaways: Companies relying on the U.S. Space Act for patent protection of inventions in orbit should be aware of exceptions to that Act that prevent such protection in certain...

Key Takeaway: The FDA’s recent discussion paper seeking feedback regarding the regulation of generative AI-enabled medical devices suggests that the FDA has focused on evaluating, monitoring, and regulating such devices...

Key Takeaway: The Senate has confirmed five new commissioners for the International Trade Commission, giving the agency a full slate of commissioners for the first time in nearly a decade,...

In the latest column in their monthly Law360 series on recent noteworthy Federal Circuit decisions, Knobbe Martens partners Jeremiah Helm and Sean Murray explore the court’s opinion in Wyeth LLC....

Key Takeaway: In a recent decision with implications for parties involved in intellectual property disputes before the International Trade Commission, an Administrative Law Judge terminated an ITC investigation based on...

In this episode of Knobbe IP+, Knobbe Martens partners Jarom Kesler and Bryan McWhorter discuss the latest developments in AI and patent eligibility. Sharing insights for both fellow IP practitioners and...

Following their discussion on the Supreme Court’s consequential decision in Hikma v. Amarin, Knobbe Martens partners Jeremiah Helm and Carol Pitzel Cruz continue their exploration of the biggest patent cases...

In this episode of IP+ with Knobbe Martens, Jeremiah Helm, Co-Chair of Knobbe Martens’ Appellate Litigation practice, and Carol Pitzel Cruz, Co-Chair of the firm’s Hatch-Waxman Litigation practice, discuss one...

Wolfspeed Sues Navitas for Patent Infringement Over GaN and SiC Technologies Sameer Khan With demand for high-efficiency power devices continuing to grow, companies are placing greater emphasis on maintaining their...

Tripling Down on Space: U.S. Space Force Expands Launch Contracts to $17B, Raising the Stakes for IP Michael E. Salamy The Space Force’s decision to triple the size of its...

No “Duty to Innovate” – California’s Highest Court Finds Gilead Sciences Not Negligent for Delaying Release of Allegedly Safer HIV Drug Ari Feinstein & Rhett D. Ramsey California court holds...

Presenting as part of an LSI ’26 panel, Knobbe Martens partners Kregg Koch and Sabing Lee joined fellow panelists to explore the complexities of intellectual property management for commercial-stage technologies in the medtech industry, and the...

As part of the firm’s 4th annual MCLE‑a‑thon, Rosaleen Chou and Jacob Rosenbaum explore strategies for acquiring, protecting, and enforcing non‑traditional trademarks, including trade dress, color, sound, and other unconventional...

As part of the firm’s 4th annual MCLE‑a‑thon, partners Jared Bunker and Lynda Zadra‑Symes review the most significant patent, trademark, and copyright decisions of 2025. The presentation covers key developments...